Analyst firms · Needham · CNMD
Needham CNMD price target and rating history
CONMED Corporation (CNMD) · Health Care
Needham rates CONMED Corporation (CNMD) Hold with a $129 price target, as of its latest action on Jun 12, 2025. It has published 5 rating actions on CNMD since October 2021, including 1 upgrade and 1 downgrade. Across 3 firms with a CNMD price target in the last 12 months, the median target is $39.
- Current rating
- Hold
- Price target
- $129
- Median target, all firms
- $39
- Actions on CNMD
- 5
Needham price target on CNMD
Every Needham rating on CNMD
- Jun 12, 2025DowngradeNeedham downgrades to Hold from Buy
- Feb 1, 2024
- Jan 21, 2022
- Oct 28, 2021
- Oct 6, 2021
How other firms rate CNMD
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| BMO Capital Markets | Market Perform | $36 | Jul 9, 2026 |
| BofA Securities | Underperform | $40 | Jun 29, 2026 |
| Piper Sandler | Neutral | $39 | Mar 17, 2026 |
Questions about Needham and CNMD
- What is Needham's price target for CNMD?
- Needham's latest stated price target for CONMED Corporation (CNMD) is $129, from its action on Feb 1, 2024.
- What is Needham's rating on CNMD?
- Needham rates CNMD Hold, a neutral rating, as of Jun 12, 2025.
- When did Needham last change its view on CNMD?
- On Jun 12, 2025, Needham downgrades to Hold from Buy.
- How does Needham's CNMD target compare with other analysts?
- Across 3 firms with a CNMD price target in the last 12 months, the median target is $39.
All Needham ratingsCNMD news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.